CoChat
Sign Up
Cited by 4Bacteriophages and microbial interactionsEnzyme Structure and FunctionTuberculosis Research and Epidemiology

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Dissecting the molecular basis underlying mycobacterial cell-wall hydrolysis by the catalytic domains of D29LysA and DS6ALysA phage endolysins

Open access
Ceballos-Zúñiga, Fernando, Galvez-Larrosa, Laura, Muñoz, Inés G., Infantes, Lourdes, Fernández-Carrillo, Juan, Pérez-Dorado, Inmaculada·2025·International Journal of Biological Macromolecules
DOI 10.1016/j.ijbiomac.2025.148896

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Abstract Mycobacteria encompass a broad range of microorganisms that cause infections with a significant impact on human health, resulting in millions of deaths each year. From tuberculosis and leprosy, caused by Mycobacterium tuberculosis and Mycobacterium leprae , respectively, to infections caused by emerging/opportunistic pathogens such as Mycobacterium abscessus . The battle to combat this health burden is further challenged by limitations in the treatments currently available and the rise of antimicrobial resistance. This underscores the need for new therapeutic strategies to combat these infections. Mycobacteriophage LysA endolysins are complex, multi-domain peptidoglycan hydrolases with reported antimicrobial relevance and the potential to treat mycobacterial infections. However, despite the therapeutic prospects of LysAs, our understanding of their mechanism of action remains limited. This study provides a comprehensive structural-functional analysis of the catalytic domains of two LysA endolysins encoded by the bacteriophages D29 and DS6A , which are known to infect pathogenic mycobacteria, including M. tuberculosis . As part of this work, we have characterized the four catalytic domains present in both endolysins ( D29 N4/ D29 GH19 and DS6A GH19/ DS6A Ami2B) both alone and in complex with PG analogues. To achieve this, we combined protein engineering, X-ray crystallography, small-angle X-ray scattering, and in silico tools. To our knowledge, this has led to the first experimental structures reported for mycobacteriophage endolysins, which reveals key aspects of peptidoglycan binding and hydrolysis by D29 LysA and DS6A LysA lysins, as well as other homologous LysAs, including the hydrolase domains similar to those examined here. Altogether, this represents a significant step forward in understanding how mycobacterial cell-wall hydrolysis occurs by this important class of endolysins and opens the door to their future use in therapeutic applications as enzybiotics. Information that will allow the rational design of a la carte enzymes with optimized lytic properties against mycobacterial pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2025.148896

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Batt, 2020, Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall, Cell Surf., 6, 10.1016/j.tcsw.2020.100044 · DOI
  2. Johansen, 2020, Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus, Nat. Rev. Microbiol., 18, 392, 10.1038/s41579-020-0331-1 · DOI · Paper page
  3. Catalão, 2019, Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis, Front. Microbiol., 10, 190, 10.3389/fmicb.2019.00190 · DOI
  4. Vollmer, 2008, Peptidoglycan structure and architecture, FEMS Microbiol. Rev., 32, 149, 10.1111/j.1574-6976.2007.00094.x · DOI
  5. Alderwick, 2015, The mycobacterial cell wall—peptidoglycan and arabinogalactan, Cold Spring Harb. Perspect. Med., 5, 1, 10.1101/cshperspect.a021113 · DOI
  6. Raymond, 2005, Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan, J. Biol. Chem., 280, 326, 10.1074/jbc.M411006200 · DOI
  7. Matsuhashi, 1966, Biosynthesis in the bacterial cell wall, Tanpakushitsu Kakusan Koso, 11, 875
  8. Vollmer, 2004, The architecture of the murein (peptidoglycan) in gram-negative bacteria: Vertical scaffold or horizontal layer(s)?, J. Bacteriol., 186, 5978, 10.1128/JB.186.18.5978-5987.2004 · DOI
  9. Dams, 2019, Enzybiotics: enzyme-based antibacterials as therapeutics, Adv. Exp. Med. Biol., 1148, 233, 10.1007/978-981-13-7709-9_11 · DOI
  10. Guo, 2023, Potential of phage depolymerase for the treatment of bacterial biofilms, Virulence, 14, 10.1080/21505594.2023.2273567 · DOI
  11. Nelson, 2001, 98(7), 4107
  12. Loeffler, 2003, Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia, Infect. Immun., 71, 6199, 10.1128/IAI.71.11.6199-6204.2003 · DOI
  13. Eniyan, 2020, Functional characterization of the endolysins derived from mycobacteriophage PDRPxv, World J. Microbiol. Biotechnol., 36
  14. Schuch, 2002, A bacteriolytic agent that detects and kills Bacillus anthracis, Nature, 418, 884, 10.1038/nature01026 · DOI
  15. Haddad Kashani, 2018, Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies, Clin. Microbiol. Rev., 31, 10.1128/CMR.00071-17 · DOI
  16. Bartlett, 2024, Targeting intracellular nontuberculous mycobacteria and M. tuberculosis with a bactericidal enzymatic cocktail, Microbiol. Spectr., 12, 10.1128/spectrum.03534-23 · DOI
  17. Carratalá, 2024, LysJEP8: a promising novel endolysin for combating multidrug-resistant Gram-negative bacteria, Micorbial Biotech., 17
  18. Sisson, 2024, Gram-negative endolysins: overcoming the outer membrane obstacle, Curr. Opin. Microbiol., 78, 10.1016/j.mib.2024.102433 · DOI
  19. Redmond, 1960, A bacteriophage specific for Mycobacterium Tuberculosis, varieties hominis and bovis, Am. Rev. Respir. Dis., 82, 781
  20. Yang, 2024, Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice, Commun. Biol., 7
  21. Froman, 1954, Bacteriophage active against virulent Mycobacterium tuberculosis 1. Isolation and activity, Am. J. Public Health Nations Health, 44, 1326, 10.2105/AJPH.44.10.1326 · DOI
  22. Gangakhedkar, 2024, Construing the function of N-terminal domain of D29 mycobacteriophage LysA endolysin in phage lytic efficiency and proliferation, Mol. Microbiol., 122, 243, 10.1111/mmi.15295 · DOI
  23. Payne, 2012, Mycobacteriophage endolysins: diverse and modular enzymes with multiple catalytic activities, PloS One, 7, 10.1371/journal.pone.0034052 · DOI
  24. Joshi, 2017, Dissecting the structure–function relationship in lysozyme domain of mycobacteriophage D29-encoded peptidoglycan hydrolase, FEBS Lett., 591, 3276, 10.1002/1873-3468.12848 · DOI
  25. Joshi, 2019, Understanding the role of the lysozyme-like domain of D29 mycobacteriophage-encoded endolysin in host cell lysis and phage propagation, Microbiology, 165, 1013, 10.1099/mic.0.000831 · DOI
  26. Urdániz, 2022, Gp29 LysA of mycobacteriophage TM4 can hydrolyze peptidoglycan through an N-acetyl-muramoyl-L-alanine amidase activity, Biochim. Biophys. Acta, Proteins Proteomics, 1870, 10.1016/j.bbapap.2021.140745 · DOI
  27. Saadhali, 2016, Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A, J. Mol. Model., 22
  28. Nair, 2024, An intramolecular cross-talk in D29 mycobacteriophage endolysin governs the lytic cycle and phage-host population dynamics, Sci. Adv., 10, 10.1126/sciadv.adh9812 · DOI
  29. Hoell, 2006, Crystal structure and enzymatic properties of a bacterial family 19 chitinase reveal differences from plant enzymes, FEBS J., 273, 4889, 10.1111/j.1742-4658.2006.05487.x · DOI
  30. Park, 2014, Structure of bacteriophage SPN1S endolysin reveals an unusual two-module fold for the peptidoglycan lytic and binding activity, Mol. Microbiol., 92, 316, 10.1111/mmi.12555 · DOI
  31. Kabsch, 2010, XDS, Acta Cryst. D, 66, 125, 10.1107/S0907444909047337 · DOI · Paper page
  32. Evans, 2013, How good are my data and what is the resolution?, Acta Cryst. D., 69, 1204, 10.1107/S0907444913000061 · DOI
  33. McCoy, 2007, Phaser crystallographic software, J. Appl. Cryst., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  34. Evans, 2022, Protein complex prediction with AlphaFold-Multimer, BioRxiv
  35. Emsley, 2010, Features and development of Coot, Acta Cryst. D, 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  36. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Cryst. D, 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  37. MacRae, 2020, Mercury 4.0: from visualization to analysis, design and prediction, J. Appl. Cryst., 53, 226, 10.1107/S1600576719014092 · DOI
  38. Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Cryst. D, 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
  39. Verdonk, 2003, Improved protein–ligand docking using GOLD, Proteins, 52, 609, 10.1002/prot.10465 · DOI
  40. Meroueh, 2006, Three-dimensional structure of the bacterial cell wall peptidoglycan, PNAS, 103, 4404, 10.1073/pnas.0510182103 · DOI
  41. Cowieson, 2020, Beamline B21: high-throughput small-angle x-ray scattering at diamond light source, J. Synchrotron Radiat., 27, 1438, 10.1107/S1600577520009960 · DOI
  42. Schneidman-Duhovny, 2016, FoXS, FoXSDock and MultiFoXS: single-state and multi-state structural modeling of proteins and their complexes based on SAXS profiles, Nucleic Acids Res., 44, W424, 10.1093/nar/gkw389 · DOI
  43. Sekiya, 2021, Structural and biochemical characterizations of the novel autolysin Acd24020 from Clostridioides difficile and its full-function catalytic domain as a lytic enzyme, Mol. Microbiol., 115, 684, 10.1111/mmi.14636 · DOI
  44. Xu, 2010, Structure of the γ-d-glutamyl-l-diamino acid endopeptidase YkfC from Bacillus cereus in complex with l-Ala-γ-d-Glu: insights into substrate recognition by NlpC/P60 cysteine peptidases, Struct. Biol. Commun., 66, 1354
  45. Böth, 2011, Peptidoglycan remodeling in Mycobacterium tuberculosis: comparison of structures and catalytic activities of RipA and RipB, J. Mol. Biol., 413, 247, 10.1016/j.jmb.2011.08.014 · DOI
  46. Griffin, 2023, Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactions, Cell Chem. Biol., 30, 436, 10.1016/j.chembiol.2022.11.001 · DOI
  47. Ozhelvaci, 2023, Identification and classification of papain-like cysteine proteinases, J. Biol. Chem., 299, 10.1016/j.jbc.2023.104801 · DOI
  48. Squeglia, 2014, Mutational and structural study of RipA, a key enzyme in Mycobacterium tuberculosis cell division: Evidence for the L-to-D inversion of configuration of the catalytic cysteine, Acta Crystallogr. D, 70, 2295, 10.1107/S1399004714013674 · DOI
  49. Martínez-Caballero, 2013, Reaction products and the X-ray structure of AmpDh2, a virulence determinant of Pseudomonas aeruginosa, J. Am. Chem. Soc., 135, 10318, 10.1021/ja405464b · DOI
  50. Low, 2011, Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins, J. Biol. Chem., 286, 34391, 10.1074/jbc.M111.244160 · DOI
  51. Sandalova, 2016, The crystal structure of the major pneumococcal autolysin LytA in complex with a large peptidoglycan fragment reveals the pivotal role of glycans for lytic activity, Mol. Microbiol., 101, 954, 10.1111/mmi.13435 · DOI
  52. Mellroth, 2014, Structural and functional insights into peptidoglycan access for the lytic amidase LytA of Streptococcus pneumoniae, ASM J, 5
  53. Büttner, 2015, X-ray crystallography and its impact on understanding bacterial cell wall remodeling processes, Int. J. Med. Microbiol., 305, 209, 10.1016/j.ijmm.2014.12.018 · DOI
  54. Büttner, 2014, Structure-function analysis of Staphylococcus aureus amidase reveals the determinants of peptidoglycan recognition and cleavage, J. Biol. Chem., 289, 11083, 10.1074/jbc.M114.557306 · DOI
  55. Iseli, 1996, Plant chitinases use two different hydrolytic mechanisms, FEBS Lett., 382, 186, 10.1016/0014-5793(96)00174-3 · DOI

Cited by

Still being checked.

Metadata

Authors
Ceballos-Zúñiga, F., Galvez-Larrosa, L., Muñoz, I. G., Infantes, L., Fernández-Carrillo, J., & Pérez-Dorado, I.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Spanish National Cancer Research Centre (ES)
ORCID
Venue
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Published
2025-12
Volume
334
Issue
Pt 1
Pages
148896
ISSN
0141-8130 (ISSN-L)
DOI
10.1016/j.ijbiomac.2025.148896
OpenAlex
W4416009356
Cited by
4
References
3
Citations by year
2026: 4
FWCI
2.13
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Biological Macromolecules (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
Funders
  • Community of Madrid (2019-T1/BMD-14774)
  • European Commission
  • Spanish National Research Council (202380E208, 2024ICT153, MMT24-IQF-01)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
peptidoglycan hydrolase, catalytic domain, substrate binding site, peptidoglycan recognition, conformational change, phage therapy, tuberculosis, antimicrobial resistance, mycobacteria
MeSH terms
Cell Wall, Hydrolysis, Models, Molecular, Mycobacteriophages, Mycobacterium, Endopeptidases, Peptidoglycan, Viral Proteins, Crystallography, X-Ray, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review